Polyethylene glycol is used to treat constipation by drawing water into the intestines to soften stool and make bowel movements easier. It's also used to cleanse the colon before medical procedures like colonoscopies.[2] GoLYTELY is currently approved and in use across 26 indications[4].[1]
GoLYTELY is one of 492 small molecule programs targeting Type 2 Diabetes Mellitus. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Application
NDA/BLA/ANDA regulatory filings
Pipeline
Competition
265 competitors in Hepatocellular Carcinoma
GoLYTELY
Ibrance
Cysteine Hydrochloride
Hepsera
Doptelet
Miraclid
Vermox
Valemetostat
Alcohol
Anti-PD-1 Monoclonal Antibody
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
Oct 6, 2006
MIRALAX
NDA NDA022015
Sources